How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?
AMA J Ethics. 2020;22(1):E43-49. doi:
10.1001/amajethics.2020.43.
A scientist-patient and patient-caregiver sit for a portrait and consider complementary therapy and its value in facilitating observation of patient-caregiver relationships.
AMA J Ethics. 2020;22(6):E565-569. doi:
10.1001/amajethics.2020.565.